Search Results

Thank you for your interest in the Applying Pharmacology to Drug Discovery course with Dr. Pharmacology is a unique discipline and is critical to drug discovery. Registrants will learn: 1. Methods to characterize the 3 major drug types. 2. What makes each drug type unique to therapeutic pharmacology? 3. Essential information needed to characterize the profile of a drug aimed at therapy.

Main objectives: - Learning how to perform advanced GPCR pharmacology data analysis in support of drug communicate GPCR pharmacology data analysis to a high level, as well as expertise that can be applied in drug

Exploring ORs in drug discovery – opportunities and threats Given the functional relevance of ORs in need to identify selective agonists or antagonists, where the starting point can be using licensed drugs (for drug repurposing) and endogenous ligands. Odorants, the natural ligands, could potentially be used as ligands and particular forms of odorant delivery delivery.

However, in drug discovery projects, perfection can’t be attained soon enough. A project to develop a perfect drug, or a drug that is as safe and effective as possible, may never begin If only Voltaire were here today to see how drug discovery is being accelerated by new technologies. Several new technologies that are being used to accelerate drug discovery are highlighted in this article screening, drug efficacy analyses, and toxicity studies; technologies that stabilize G protein–coupled

It has particular relevance in the field of drug discovery, offering transformative potential across Target Identification and Validation In drug discovery, the identification of robust drug targets is Predicting and Overcoming Drug Resistance A significant challenge in drug development, particularly in therapeutic indices to produce safer and more effective drugs. Predicting Drug Resistance Using Deep Mutational Scanning.

(GPCRs) have been investigated for active targeting with nanomedicines such as antibody-conjugated drugs and drug-loaded nanoparticles, highlighting a neglected potential to develop personalised treatment. GPCRs expressed in cancer biopsies, matched with personalised GPCR-targeted nanomedicines, for the delivery of lethal drugs to tumour tissue before, during and after surgery. delivery , GPCR , Nanomedicine , Ovarian cancer , Personalised medicine , RNA-seq Source Contribute

Although GPCRs are the molecular targets of the majority of marketed drugs, the poor pharmacokinetics Moreover, endosomal delivery of GPCR ligands by nanoparticles can precisely initiate sustained endosomal This significantly enhances the potency of nanoparticle delivery systems. Nanotechnology has also been applied to construct synthetic nano-GPCRs or detect GPCRs, while endosomal delivery delivery , Endosomal delivery , G protein-coupled receptors (GPCRs) , Molecular targeting , Nanoparticles

treatment of GBM is challenging due to the presence of the blood-brain barrier (BBB), which hinders drug delivery. Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs